Xiao stressed that the CIIE is offering Swiss companies a valuable opportunity to engage with local governments, professionals and industry leaders.

In light of current economic uncertainties, Xiao is optimistic about the future of business cooperation between China and Europe.

He noted that despite fluctuating uncertainties, China remains an attractive market, especially in the healthcare sector, where the demand in China aligns well with the innovative capabilities of Swiss companies.

As a leading company in the medical devices industry, BD plays a significant role in global medical innovation, Deng said, noting that over the past four years, BD has visited some of the world's top technology parks to refine an incubation model that aims to create a high-quality platform for companies to enter the Chinese market and develop sustainably.

While sharing BD's future plans to help Chinese companies invest abroad, creating a dual-circulation model of "bringing in and going out" that will foster innovation in China and present a new phase of China's reform and opening-up to the outside world, Deng said BD has also expanded its efforts in line with the CIIE's goals of high-standard opening-up and development, exploring policies to offer companies a more comprehensive and deeper platform.

Deng stated BD's network includes 43 member companies in the Expo Alliance and numerous top funds in the Mednovation Club, providing all companies with an attractive platform.

It has been learned that in the Medical Innovation Incubation Zone, the close collaboration between Chinese and European companies, the convergence of innovative technologies and market needs, and the supportive interaction between policies and corporate growth are a vogue.

These factors can help drive innovation in the healthcare industry and contribute Chinese wisdom and solutions to global health initiatives, Deng said, adding that the incubation zone has once again demonstrated its crucial role in promoting international cooperation and advancing medical innovation.

Please contact the writer at hanjingyan@chinadaily.com.cn